Understanding these interconnected networks between PD-1 immunology and distinct cell populations related to renal cell carcinoma, glomerulonephritis, kidney transplantation, or renal aging will be critical to the development of novel drugs targeting PD-1 signaling. The gene discussed is PDCD1; the disease is hereditary clear cell renal cell carcinoma.